VectivBio Holding AG announced that Paul R. Carter and Dr. Murray W. Stewart were elected as new members of the Board of Directors at the Extraordinary General Meeting held on September 2, 2021. Mr. Paul R. Carter served in senior executive roles for a decade at Gilead Sciences, most recently as Executive Vice President of Commercial Operations, leading Gilead’s launch and commercialization efforts globally. Previously, he worked for 15 years at GlaxoSmithKline (GSK), where he served in increasingly senior management roles in a number of territories, including as Head of International Business in Asia. Over the past five years, Mr. Carter has been involved with several public and private biopharmaceutical companies as a Board Member and Senior Advisor. He is a Fellow of the Chartered Institute of Management Accountants in the UK and holds a degree in Business Studies from the Ealing School of Business and Management. Murray W. Stewart, DM, FRCP, is the Chief Medical Officer of Rhythm Pharmaceuticals.